As countries across the world, and some US states continue to impose harsh lockdowns in response to the Omicron variant of Covid-19, the US army is completing Phase 1 of human trials for a vaccine that would reportedly protect against all known variants.  The New York Post Reports

“The US Army has developed a vaccine to fight all variants of COVID-19, including Omicron and Delta — as well as all prior coronaviruses and strains not yet identified.

Scientists at the Walter Reed Army Institute of Research expect to announce the one-stop shot in just weeks after nearly two years of research that began with the DNA sequencing of the COVID-19 virus in early 2020, Defense One reported late Tuesday.

Infectious disease specialists at the Department of Defense’s largest biomedical research facility completed animal trials earlier this year with its spike ferritin nanoparticle vaccine, or SpFN, with positive results, according to the report.

Trending: America Responds To AT&T’s Decision To Drop OANN From Direct TV

Phase 1 of its human trials are now under final review after testing against Omicron and other variants was completed earlier this month — again with promising results, the director of Walter Reed’s infectious disease branch told Defense One.”

The vaccine reportedly contains a soccer ball-shaped protein with 24 faces, which allows scientists to attach different variants of the coronavirus to the protein, offering protection from all known variants and variants not yet identified.

Join The Conversation. Leave a Comment.


We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.